Search

Your search keyword '"Peura JL"' showing total 7 results
Start Over Author "Peura JL"
7 results on '"Peura JL"'

2. Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association.

Author

Peura JL, Colvin-Adams M, Francis GS, Grady KL, Hoffman TM, Jessup M, John R, Kiernan MS, Mitchell JE, O'Connell JB, Pagani FD, Petty M, Ravichandran P, Rogers JG, Semigran MJ, Toole JM, and American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology

Published
2012
Full Text
View/download PDF

3. A Ventricular Assist Device Recipient and Suicidality: Multidisciplinary Collaboration With a Psychiatrically Distressed Patient.

Author

Balliet WE, Madan A, Craig ML, Serber ER, Borckardt JJ, Pelic C, Barth K, Hale A, van Bakel AB, and Peura JL

Subjects
Adult, Humans, Male, Depressive Disorder psychology, Heart Failure psychology, Heart Failure therapy, Heart-Assist Devices, Suicide psychology
Abstract

Background: Ventricular assist device (VAD) recipients are at high risk of depression and anxiety, and poor psychosocial functioning is associated with worse medical outcomes., Purpose: We present a case of a 31-year-old depressed patient who demonstrated passive suicidal behavior through multiple episodes of noncompliance, including temporarily discontinuing warfarin (Coumadin) several months after VAD implantation. The patient's psychosocial and medical histories and outcomes are presented., Conclusions: This case underscores the importance of pre-VAD as well and ongoing psychosocial evaluation and management for this unique patient population., Clinical Implications: Medical teams who are treating patients with cardiovascular disease who are under consideration for VAD or heart transplantation need to be aware of the multitude of ways in which patients can express depressed and suicidal mood and work with a multidisciplinary team to treat such symptoms to optimize patients' success with VAD/heart transplantation., Competing Interests: The authors have no conflicts of interest that are directly relevant to the content of this study. One table is presented

Published
2017
Full Text
View/download PDF

5. Interactions between a left ventricular assist device and implantable cardioverter-defibrillator.

Author

Netzler PC, Vasuki N, Peura JL, and Gold MR

Subjects
Female, Humans, Middle Aged, Artifacts, Defibrillators, Implantable, Equipment Failure, Heart-Assist Devices
Abstract

Left ventricular assist devices (LVADs) are approved for both a bridge to cardiac transplantation as well as for destination therapy. Most patients with LVADs have implantable cardioverter-defibrillators (ICDs) and several interactions between LVADs and ICDs have been reported. In the present case, we describe an interaction of an approved LVAD with remote telemetry of a previously implanted Sorin ICD (Sorin Group, Milan, Italy) that could not be resolved with standard shielding techniques., (©2012, The Authors. Journal compilation ©2012 Wiley Periodicals, Inc.)

Published
2012
Full Text
View/download PDF

6. Cardiac transplantation at MUSC: 24 years of experience and change.

Author

Crumbley AJ 3rd, Van Bakel AB, Stroud MR, Uber W, Toole JM, Peura JL, Craig ML, Yarbrough WM, and Ikonomidis JS

Subjects
Adolescent, Adult, Aged, Child, Child, Preschool, Female, Follow-Up Studies, Heart Diseases mortality, Heart Transplantation mortality, Hospital Mortality trends, Humans, Infant, Infant, Newborn, Male, Middle Aged, Retrospective Studies, South Carolina epidemiology, Survival Rate trends, Time Factors, Treatment Outcome, Young Adult, Heart Diseases surgery, Heart Transplantation trends, Hospitals, University
Published
2011

7. Effects of conversion from cyclosporine to tacrolimus on left ventricular structure in cardiac allograft recipients.

Author

Peura JL, Zile MR, Feldman DS, VanBakel AB, McClure C, Uber W, Haynes H, and Pereira NL

Subjects
Female, Hemodynamics drug effects, Humans, Male, Middle Aged, Prospective Studies, Transplantation, Homologous, Cyclosporine pharmacology, Heart Transplantation, Heart Ventricles drug effects, Immunosuppressive Agents pharmacology, Tacrolimus pharmacology, Ventricular Remodeling drug effects
Abstract

Twelve heart transplant recipients selected for conversion from cyclosporine to tacrolimus because of adverse effects of cyclosporine therapy underwent echocardiography at baseline and 6 months after conversion. Left ventricular mass decreased by 24% and left ventricular geometry returned toward normal at 6 months after conversion, without significant changes in blood pressure.

Published
2005
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results